What’s the Outlook for Pfizer Stock?

1 min read

Pfizer (NYSE: PFE) underperformed the S&P 500 in 2020. And in 2019. And in 2017. And in 2016. You probably noticed I skipped 2018 — that was the only year in the past five when the big drugmaker managed to beat the broad-market index. If looking at historic returns was the best way to predict future returns, Pfizer’s outlook wouldn’t be all that good.

However, there’s a reason that the investment world includes so many disclaimers warning that “past performance may not be indicative of future results.” Things change. That’s especially true in cases when a business’s underlying dynamics have shifted as much as Pfizer’s have. So what’s the outlook for Pfizer stock? Probably a lot better than it has been in recent years.

Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Madison Square Garden Entertainment Corp. (MSGE) Q2 2021 Earnings Call Transcript

Next Story

2 Top Value Stocks to Buy Now

Latest from Blog